DHEA vs Gonadorelin
A side-by-side research comparison of DHEA and Gonadorelin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | DHEA | Gonadorelin |
|---|---|---|
| Full name | Dehydroepiandrosterone | Gonadorelin (GnRH Analog) |
| Category | Hormone Replacement | Hormone Replacement |
| Status | OTC supplement / Prescribed | FDA Approved |
| Mechanism | Serves as a precursor to both testosterone and estrogen. Also acts directly on DHEA-specific receptors, supports immune function, neurosteroid activity, and cellular metabolism. | Binds GnRH receptors on pituitary gonadotrophs to stimulate LH and FSH release, maintaining testicular/ovarian function and natural sex hormone production. |
| Molecular weight | 288.42 Da | 1182.39 Da |
| Half-life | 15-38 hours | ~10-40 minutes |
| Bioavailability | ~100% oral | ~90% subcutaneous |
| Typical dose | 25-100 mg | 100-500 mcg |
| Frequency | Daily (morning) | 2-3x per week or pulsatile |
| Route | Oral capsule or topical cream | Subcutaneous injection |
DHEA reported benefits
- Hormone precursor support
- Improved energy levels
- Bone density support
- Cognitive function
- Immune enhancement
- Anti-aging
Gonadorelin reported benefits
- Maintains natural hormone production
- Fertility preservation
- Testicular function support
- LH/FSH normalization
Related comparisons
Research and educational reference only. Not medical advice.